Panagora Asset Management Inc Seelos Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.59 - $2.38 $156,069 - $233,613	-98,157 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$2.64 - $6.32 $259,134 - $620,352	98,157 New	98,157 $259,000
Q3 2020 Nov 13, 2020	SELL	$0.6 - $1.25 $799 - $1,665	-1,332 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$0.72 - $1.52 $959 - $2,024	1,332 New	1,332 $2,000
Q3 2019 Nov 12, 2019	SELL	$0.92 - $2.15 $1,263 - $2,951	-1,373 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$2.11 - $3.3 $8,688 - $13,589	-4,118 Reduced 75.0%	1,373 $3,000
Q1 2019 May 15, 2019	BUY	$1.45 - $8.1 $7,961 - $44,477	5,491 New	5,491 $18,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.